01 January 2005
Money for consent--psychological consideration.
David Mayrhofer-Reinhartshuber, Annelies Fitzgerald, Robert D FitzgeraldAnn Transplant 2005; 10(1): 26-29 :: ID: 142744
Abstract
CONTEXT: Regarding the increasing gap between demand and supply of donororgans the question is increasingly discussed, if families of organ donors should receive a financialincentive for consenting to organ donation. However, little attention has been paid to the psychologicalconsequences of such incentives. OBJECTIVE: We discuss the question of financial incentives for familiesof presumed organ donors in the light of relevant psychological theories. DATA SOURCES AND STUDY SELECTION:Overview of the psychological literature. Only well established theories were included. CONCLUSIONS:We summarise, that financial benefits for consent to organ donoation could affect adversely the publicopinion toward organ donation and the whole process of transplantation and thus could counterproductivelyinfluence the consent rates.
Keywords: Cognitive Dissonance
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






